COVID-19 與流感的鑑別診斷有助於及時做出治療決策

COVID-19 與流感的鑑別診斷有助於及時做出治療決策

無法預測 COVID-19 及流感季節的嚴重程度

Webinar Webinar Webinar

隨著安全社交距離措施的降低,流感傳播程度可能增加。1專家認為 COVID-19 疫情會在此時繼續傳播。因此,COVID-19 及流感都有可能共同傳播。快速檢測仍然是管理難以預測的呼吸道疾病最重要的方法。2

註冊以觀看此網路研討會的錄影

無法預測 COVID-19 及流感季節的嚴重程度

隨著安全社交距離措施的降低,流感傳播程度可能增加。1專家認為 COVID-19 疫情會在此時繼續傳播。因此,COVID-19 及流感都有可能共同傳播。快速檢測仍然是管理難以預測的呼吸道疾病最重要的方法。2

註冊以觀看此網路研討會的錄影

Webinar Webinar Webinar

COVID-19 與流感具有相似的症狀,使推定診斷變得困難

infographic infographic infographic

COVID-19 及流感常見的共同症狀,如發燒、咳嗽和呼吸急促等,因此很難僅根據症狀區分。3

COVID-19 與流感具有相似的症狀,使推定診斷變得困難

COVID-19 及流感常見的共同症狀,如發燒、咳嗽和呼吸急促等,因此很難僅根據症狀區分。3

infographic infographic infographic

比往常更需要進行診斷,以適當識別、治療及控制傳播

早期研究顯示,可能同時感染 COVID-19 及流感,並可能導致患者預後情況更差,這表示在即將到來的流感季節監測這兩種疾病更為重要。

  • 實驗性共同感染發現如果預先感染 A 型流感病毒,會明顯增加 SARS-CoV-2 的傳染性。 (2021)4
  • 綜合文獻的結論表示,出現合併感染時,病理生理學更複雜,合併感染會導致更大的肺部損傷。(2021 年 6 月)5
  • 單一中心研究發現,同時感染 SARS-CoV-2 及 B 型流感病毒的患者出現不良預後的風險更高(2021 年 11 月)6
白皮書:SARS-CoV-2 合併感染 - 流感及其他病原體

 

世界衛生組織指南支持對流感及 SARS-CoV-27 進行檢測7

世界衛生組織 (WHO) 敦促各國在 COVID-19 期間對流感的檢測務必保持警惕。

「採取適當行動確保有效檢測和監測流感及 SARS-CoV-2 的充分檢測至關重要。」
- 世界衛生組織關於病毒分化

「這兩種感染通常有類似的臨牀表現 [...]. 因此,有必要區分這兩種病毒和相關疾病。」
- 世界衛生組織對高危險患者進行檢測

「罹患嚴重或複雜疾病或有危險因素的患者,應使用快速分子檢測進行檢測,可在 24 小時內獲得結果」

快速測試可以獲得 COVID-19 及流感的快速準確診斷,以保護社區

保持警惕 保持警惕 保持警惕

監測

在不可預測的季節追蹤社區傳播

保持警惕 保持警惕 保持警惕

控制

盡快實施感染控制措施

保持警惕 保持警惕 保持警惕

及早治療

及時提供抗病毒流感或 COVID-19 治療以改變結果

呼吸系統診斷解決方案

Abbott 擁有快速的定點照護解決方案,滿足您的 COVID-19 及流感檢測需求

參考

  1. Ahmed et al, Effectiveness of workplace social distancing measures in reducing influenza transmission: a systematic review. BMC Public Health. 2018;18:518. doi: https://doi.org/10.1186/s12889-018-5446-1
  2. Phillips N.. The coronavirus is here to stay —here’s what that means. Nature. 2021; 590: 382-384. doi: https://doi.org/10.1038/d41586-021-00396-2.
  3. US Centers for Disease Control and Prevention website. “Similarities and Differences between Flu and COVID-19.” Page reviewed June 7, 2021. Link
  4. Bai, L., Zhao, Y., Dong, J. et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Res 31, 395–403 (2021). (Link).
  5. Covin, S, Rutherford G. Coinfection, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and Influenza: An Evolving Puzzle. Clinical Infectious Diseases. 15 June 2021; 72(12), e993–e994. (Link)
  6. Yue H, Zhang M, Xing L, et al. The epidemiology and clinical characteristics of co‐infection of SARS‐CoV‐2 and influenza viruses in patients during COVID‐19 outbreak. J Med Virol. 2020 Nov; 92(11):2870-2873. (Link- abstract)  (Link-Full paper-requires login)
  7. WHO Policy Brief “Readiness for Influenza during the COVID-19 pandemic.”  World Health Organization. 6 November 2020. (Link)

©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement | Declaration for California Compliance Law.

Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.